These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16594268)

  • 21. GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?
    Bailey JE; Nutt DJ
    Pharmacol Biochem Behav; 2008 Jul; 90(1):51-7. PubMed ID: 18485466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects.
    Cameron OG; Smith CB; Lee MA; Hollingsworth PJ; Hill EM; Curtis GC
    Biol Psychiatry; 1990 Jul; 28(1):3-20. PubMed ID: 2165422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The neuropeptide cholecystokinin and anxiety states].
    Cohen H; Kaplan Z
    Harefuah; 1996 May; 130(10):707-10. PubMed ID: 8794666
    [No Abstract]   [Full Text] [Related]  

  • 24. The diagnostic validity of anxiety disorders and their relationship to depressive illness.
    Breier A; Charney DS; Heninger GR
    Am J Psychiatry; 1985 Jul; 142(7):787-97. PubMed ID: 2861752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcoholism and panic disorder: is the comorbidity more than coincidence?
    George DT; Nutt DJ; Dwyer BA; Linnoila M
    Acta Psychiatr Scand; 1990 Feb; 81(2):97-107. PubMed ID: 2183544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptides and anxiety: focus on cholecystokinin.
    Lydiard RB
    Clin Chem; 1994 Feb; 40(2):315-8. PubMed ID: 8313613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotransmitters in anxiety.
    Hoehn-Saric R
    Arch Gen Psychiatry; 1982 Jun; 39(6):735-42. PubMed ID: 6124225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noradrenergic and serotonergic receptor system function in panic disorder and depression.
    Heninger GR; Charney DS; Price LH
    Acta Psychiatr Scand Suppl; 1988; 341():138-50. PubMed ID: 3048049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cholecystokinin hypothesis of anxiety and panic disorder.
    Bradwejn J; Koszycki D
    Ann N Y Acad Sci; 1994 Mar; 713():273-82. PubMed ID: 8185169
    [No Abstract]   [Full Text] [Related]  

  • 30. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR; Breier A
    Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
    Bradwejn J; Koszycki D; Shriqui C
    Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two faces of cholecystokinin: anxiety and schizophrenia.
    Bourin M; Malinge M; Vasar E; Bradwejn J
    Fundam Clin Pharmacol; 1996; 10(2):116-26. PubMed ID: 8737954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiety and growth disturbance: is there a connection? A review of biological studies in social phobia.
    Uhde TW
    J Clin Psychiatry; 1994 Jun; 55 Suppl():17-27. PubMed ID: 8077162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors.
    Grunhaus LJ; Cameron O; Pande AC; Haskett RF; Hollingsworth PJ; Smith CB
    Acta Psychiatr Scand; 1990 Mar; 81(3):216-9. PubMed ID: 2160772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biology of anxiety.
    Teicher MH
    Med Clin North Am; 1988 Jul; 72(4):791-814. PubMed ID: 2836673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of GABA in anxiety and depression.
    Kalueff AV; Nutt DJ
    Depress Anxiety; 2007; 24(7):495-517. PubMed ID: 17117412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to hyperventilation and inhalation of 5.5% carbon dioxide-enriched air across the DSM-III-R anxiety disorders.
    Rapee RM; Brown TA; Antony MM; Barlow DH
    J Abnorm Psychol; 1992 Aug; 101(3):538-52. PubMed ID: 1500611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced benzodiazepine sensitivity in panic disorder.
    Roy-Byrne PP; Cowley DS; Greenblatt DJ; Shader RI; Hommer D
    Arch Gen Psychiatry; 1990 Jun; 47(6):534-8. PubMed ID: 2161643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.